ION expands ETF trading capabilities with Tradeweb integration
Magnera Corp (NYSE:MAGN) announced Friday that it expects to hold its annual meeting of shareholders on March 9, 2026. The company stated that further details regarding the meeting will be provided in its upcoming proxy statement, which will be filed with the Securities and Exchange Commission and made available to shareholders at a later date. The announcement comes as MAGN shares have surged 19.41% over the past week, though they remain down 24.16% year-to-date. According to InvestingPro analysis, the stock appears slightly undervalued with a current price of $13.78.
Shareholders who wish to have a proposal included in the proxy statement under Rule 14a-8 of the Securities Exchange Act must submit their proposals in writing to the company’s corporate secretary by December 9, 2025. According to the filing, this date is considered a reasonable time before Magnera Corp plans to begin printing and distributing proxy materials.
Additionally, shareholders intending to bring director nominations or other proposals before the annual meeting—outside of the Rule 14a-8 process—must also deliver written notice to the corporate secretary by December 9, 2025, in accordance with the company’s bylaws.
The information is based on a statement from Magnera Corp’s press release filed with the SEC.
In other recent news, Magnera Corporation reported its fourth-quarter earnings, revealing a modest revenue beat with sales reaching $839 million, surpassing expectations of $834.06 million. This positive outcome highlights the company’s strong operational performance and strategic initiatives. Additionally, Wells Fargo upgraded Magnera’s stock from Equal Weight to Overweight, raising the price target to $16.00 from $12.00. The upgrade was attributed to management’s efforts to stabilize the business, with Wells Fargo noting a credible EBITDA growth story for fiscal year 2026 due to self-help initiatives and synergies. These developments indicate significant progress in Magnera’s business strategy and financial health.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.